Progenics Pharmaceuticals IncPGNX:NSQ

0.06 / 1.69 %
23.58 %
Close in USDToday's changeShares traded1 year changeBeta
As of Apr 17 2014 21:00 BST.Data delayed by at least 15 minutes.


On Thursday, Progenics Pharmaceuticals Inc (PGNX:NSQ) closed at 3.50, 9.38% above its 52-week low of 3.20, set on Apr 15, 2014.

52-week range
Apr 15 2014
Jan 17 2014
Day high3.73
Day low3.44
Previous close3.56
Average volume1.15m
Shares outstanding69.58m
Free float67.65m
P/E (TTM)--
Market cap243.51m USD
EPS (TTM)-0.7766 USD

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Progenics Pharmaceuticals Inc-6.42 %-19.17 %-15.66 %-23.58 %-40.58 %
S&P 500 INDEX+2.71 %-0.40 %+6.90 %+20.97 %+114.45 %
USA/HEALTH CARE+2.09 %-4.48 %+7.40 %+16.24 %--
USA/BIOTECHNOLOGY+4.52 %-12.87 %+2.07 %+17.44 %--
As of Apr 17 2014 21:00 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.